go to contents

THT BIOMATERIALS GmbH

Back to list

Facts

Founded
2020
Staff
3
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Focus
consumables / reagents

Profile

THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components (https://tht-biomaterials.com).

R&D:In vitro toxicoty, in vitro diagnostics (cancer)/drug development. Bioaktive tissue-ink. 2D coating/3D gel. Organoids. Filler and wound healing.

Production:HUMAN PLACENTA Collagen-I, liquid or freece-dried. HUMAN PLACENTA Laminin-111. HUMAN PLACENTA Substrate (hpS).

Similar companies in RDM biotech/pharma

piCHEM Forschungs- und Entwicklungs GmbH

Organization type
RDM biotech/pharma
Region
Styria
Cluster
Human.technology Styria
Focus
non-specific applications
Details

Pregenerate GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Focus
bioinformatics
Details

APEPTICO Forschung und Entwicklung GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

SELO Medical GmbH

Organization type
RDM biotech/pharma
Region
Salzburg
Details

Contact

Dr.-Bohr-Gasse 7
1030 Wien
Vienna

Contact: Johannes Hackethal (CTO)
Email: office@tht-biomaterials.com
Website